Journal of Pain and Symptom Management
Volume 38, Issue 4 , Pages 578-586 , October 2009

Prediction of Survival Time in Advanced Cancer: A Prognostic Scale for Chinese Patients

  • Zhou Lingjun, MS

      Affiliations

    • Department of Nursing, Changhai Hospital, Second Military Medical University, Shanghai, China
    • ,
  • Cui Jing, MS

      Affiliations

    • Department of Nursing, Changhai Hospital, Second Military Medical University, Shanghai, China
    • ,
  • Lu Jian, MD, MPH

      Affiliations

    • Department of Health Statistics, Second Military Medical University, Shanghai, China
    • ,
  • Bee Wee, MA (Oxon), PhD, FRCP, MRCGP, MA Ed

      Affiliations

    • Sir Michael Sobell House, Churchill Hospital, Oxford, United Kingdom
    • ,
  • Zhao Jijun, BSc

      Affiliations

    • Department of Nursing, Changhai Hospital, Second Military Medical University, Shanghai, China
    • Corresponding Author InformationAddress correspondence to: Zhao Jijun, BSc, Department of Nursing, Changhai Hospital, Second Military Medical University, No. 168, Changhai Road, Shanghai, China.

,Accepted 2 January 2009.

References 

  1. Vigano A, Dorgan M, Bruera E, Suarez-Almazor ME. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer. 1999;86:170–176
  2. Chritakis NA, Lamont EB. Extent and determinants of error in doctors' prognosis in terminally ill patients: prospective cohort study. BMJ. 2000;230:469–472
  3. Glare P, Virik K, Jones M, et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ. 2003;327:195–198
  4. Chow E, Harth T, Hruby G, et al. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol. 2001;13:209–218
  5. Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12:5–11
  6. Lau F, Downing GM, Lesperance M, Shaw J, Kuziemsky C. Use of palliative performance scale in end-of-life prognostication. J Palliat Med. 2006;9:1066–1075
  7. Weng LC, Huang HL, Wilkie DJ, et al. Predicting survival with the palliative performance scale in a minority-serving hospice and palliative care program. J Pain Symptom Manage. 2009;37(4):642–648
  8. Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage. 1999;17:231–239
  9. Glare P, Virik K. Independent perspective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage. 2001;22:891–898
  10. Morita T, Tsunoda J, Inoue S, Chihara S. The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7:128–133
  11. Chuang RB, Hu WY, Chiu TY, Chen CY. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage. 2004;28:115–122
  12. Bozcuk H, Koyuncu E, Yildiz M, et al. A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients. Int J Clin Pract. 2004;58:1014–1019
  13. Schonwetter RS, Robinson BE, Ramirez G. Prognostic factors for survival in terminal lung cancer patients. J Gen Intern Med. 1994;9:356–371
  14. Tian XF, Ping XY, Dai YP. Causes of overtreatment and reply strategy. Med Philos. 2003;24:10–12
  15. Gu JC, Shi YX. Research and development of palliative care. Tumor J World. 2004;3:207–210
  16. Su YF. The study on locally developments of hospice. J Chin Med Ethics. 2005;18:30–31
  17. Lang LW, Li HL, Shen LM, et al. A qualitative study on status quo of hospice care and its strategies in general hospitals. Chin Nurs Res. 2006;2:2342–2344
  18. Yu Y, Zhou LL. Consideration on strategy and developing trend of hospice care in China. Med Philos. 2006;27:65–66
  19. Shanghai Cancer Report 2007. Shanghai Municipal Center for Disease Control & Prevention. Shanghai, China. No. SCDC-01-2007-010-01. 2007:1–2.
  20. Sun Y. China: status of cancer pain and palliative care. J Pain Symptom Manage. 1993;8:399–403
  21. Sun Y. Medical oncology. Beijing: People's Medical Publishing House; 2005;996–997
  22. Glare P. Clinical predictors of survival in advanced cancer. J Support Oncol. 2005;3:331–339
  23. Hwang SS, Scott CB, Chang VT, et al. Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky Performance Status, quality of life, and symptom distress. Cancer Invest. 2004;22:678–687
  24. Viganò A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med. 2000;14:363–374
  25. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med. 1988;148:1586–1591
  26. Maltoni M, Caraceni A, Brunelli C, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the steering committee of the European Association for Palliative Care. J Clin Oncol. 2005;23:6240–6248
  27. Vigano A, Bruera E, Jhangri GS, et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160:861–868
  28. Bhatnagar S, Mishra S. Determining prognosis in patients with advanced incurable cancer. Indian J Med Paed Oncology. 2006;27:19–20
  29. Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage. 1995;10:423–431
  30. Shadbolt B, Barresi J, Craft P. Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol. 2002;20:2514–2519
  31. Langendijk H, Aaronson NK, de Jong JM, et al. The prognostic impact of quality of life assessed with the EORTC QLQ C-30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol. 2000;55:19–25
  32. Sutchffe J, Holmes S. Dehydration: burden or benefit to the dying patient?. J Adv Nurs. 1994;19:71–76
  33. Fainsinger RL, Bruera E. When to treat dehydration in a terminally ill patient?. Support Care Cancer. 1997;5:205–211
  34. Miyashita M, Morita T, Shima Y, et al. Physician and nurse attitudes toward artificial hydration for terminally ill cancer patients in Japan: results of 2 nationwide surveys. Am J Hosp Palliat Med. 2007;24:383–389
  35. Hallenbeck JL. Palliative care perspectives. New York: Oxford University Press; 2003;
  36. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289:2387–2392
  37. McCusker J. The terminal period of cancer: definition and descriptive epidemiology. J Chronic Dis. 1984;37:377–385
  38. Llobera J, Esteva M, Rifa J, et al. Terminal cancer: duration and prediction of survival time. Eur J Cancer. 2000;36:2036–2043
  39. Higginson IJ, Finlay IG, Goodwin DM, et al. Is there evidence that palliative care teams alter end-of-life experience in patients and their caregivers?. J Pain Symptom Manage. 2003;25:150–168
  40. Mintzer DM, Zagrabbe K. On how increasing numbers of newer cancer therapies further delay referral to hospice: the increasing palliative care imperative. Am J Hosp Palliat Med. 2007;24:126–130
  41. Lau F, Cloutier-Fisher D, Kuziemsky C, et al. A systematic review of prognostic tools for estimating survival time in palliative care. J Palliat Care. 2007;23:93–112

 The study was supported by the Shanghai Leading Academic Discipline Project (Grant No. B903).

PII: S0885-3924(09)00575-2

doi: 10.1016/j.jpainsymman.2008.12.005

Journal of Pain and Symptom Management
Volume 38, Issue 4 , Pages 578-586 , October 2009

Article Tools

* Image Usage & Resolution